Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $250M; returns 1 day -7.6%, 1 week +6.6%, 1 year +147.5%.

Century Therapeutics, Inc. (IPSC) is a clinical-stage biotechnology company focused on developing allogeneic cell therapies from induced pluripotent stem cells (iPSCs) for treating solid tumors, hematological malignancies, and autoimmune diseases.

Groups IPSC belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Hematologic Malignancies
• Autoimmune Diseases
• Life Sciences
• Healthcare
• R&D
• Biopharmaceutical

IPSC financial model: income statement, cash flow and balance sheet